AZENTA INC (AZTA) Stock Fundamental Analysis
USA - NASDAQ:AZTA - US1143401024 - Common Stock
30.2 USD
+0.3 (+1%)
30.2 USD
0 (0%)
AZTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for AZTA as it has an excellent financial health rating, but there are worries on the profitability. AZTA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AZTA had positive earnings in the past year.
AZTA had a positive operating cash flow in the past year.
In multiple years AZTA reported negative net income over the last 5 years.
Of the past 5 years AZTA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.53%, AZTA is in line with its industry, outperforming 51.72% of the companies in the same industry.
AZTA's Return On Equity of -6.67% is in line compared to the rest of the industry. AZTA outperforms 53.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.53% | ||
| ROE | -6.67% | ||
| ROIC | N/A |
ROA(3y)16.36%
ROA(5y)11.87%
ROE(3y)17.86%
ROE(5y)13.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AZTA has a Gross Margin (44.92%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AZTA has remained more or less at the same level.
AZTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.44%
GM growth 5Y-0.19%
2. Health
2.1 Basic Checks
AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
AZTA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AZTA has less shares outstanding
AZTA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.85 indicates that AZTA is not in any danger for bankruptcy at the moment.
AZTA has a Altman-Z score of 3.85. This is in the better half of the industry: AZTA outperforms 72.41% of its industry peers.
There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.85 |
ROIC/WACCN/A
WACC10.54%
2.3 Liquidity
A Current Ratio of 2.76 indicates that AZTA has no problem at all paying its short term obligations.
With a Current ratio value of 2.76, AZTA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
AZTA has a Quick Ratio of 2.44. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AZTA (2.44) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.76 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.89%, which is quite impressive.
Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.07% on average per year.
Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -8.15% in the last year.
AZTA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.41% yearly.
EPS 1Y (TTM)38.89%
EPS 3Y-45.83%
EPS 5Y-12.07%
EPS Q2Q%18.75%
Revenue 1Y (TTM)-8.15%
Revenue growth 3Y8.51%
Revenue growth 5Y-3.41%
Sales Q2Q%-16.7%
3.2 Future
AZTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.43% yearly.
The Revenue is expected to grow by 2.23% on average over the next years.
EPS Next Y23.89%
EPS Next 2Y38.51%
EPS Next 3Y34.3%
EPS Next 5Y29.43%
Revenue Next Year-9.78%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.64%
Revenue Next 5Y2.23%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 60.40, the valuation of AZTA can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of AZTA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.11, AZTA is valued quite expensively.
With a Price/Forward Earnings ratio of 38.40, AZTA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AZTA is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
AZTA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.55.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.4 | ||
| Fwd PE | 38.4 |
4.2 Price Multiples
63.79% of the companies in the same industry are more expensive than AZTA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 74.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.31 | ||
| EV/EBITDA | 28.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AZTA does not grow enough to justify the current Price/Earnings ratio.
AZTA's earnings are expected to grow with 34.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.53
PEG (5Y)N/A
EPS Next 2Y38.51%
EPS Next 3Y34.3%
5. Dividend
5.1 Amount
AZTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.2
+0.3 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners116.57%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change1.52%
Market Cap1.38B
Revenue(TTM)604.93M
Net Income(TTM)-111586000
Analysts71.43
Price Target32.79 (8.58%)
Short Float %7.17%
Short Ratio6.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.12%
Min EPS beat(2)-29.97%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)28.83%
Min EPS beat(4)-29.97%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)146.76%
EPS beat(12)10
Avg EPS beat(12)157.49%
EPS beat(16)13
Avg EPS beat(16)123.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.89%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.14%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.03%
Revenue beat(16)7
Avg Revenue beat(16)-4.7%
PT rev (1m)2.27%
PT rev (3m)2.37%
EPS NQ rev (1m)-0.73%
EPS NQ rev (3m)4.34%
EPS NY rev (1m)0.06%
EPS NY rev (3m)13.01%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.4 | ||
| Fwd PE | 38.4 | ||
| P/S | 2.29 | ||
| P/FCF | 30.31 | ||
| P/OCF | 16.54 | ||
| P/B | 0.83 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 28.12 |
EPS(TTM)0.5
EY1.66%
EPS(NY)0.79
Fwd EY2.6%
FCF(TTM)1
FCFY3.3%
OCF(TTM)1.83
OCFY6.05%
SpS13.2
BVpS36.51
TBVpS18.8
PEG (NY)2.53
PEG (5Y)N/A
Graham Number20.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.53% | ||
| ROE | -6.67% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% | ||
| FCFM | 7.55% |
ROA(3y)16.36%
ROA(5y)11.87%
ROE(3y)17.86%
ROE(5y)13.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.44%
GM growth 5Y-0.19%
F-Score7
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 53.88% | ||
| Cap/Sales | 6.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 231.56% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.76 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 3.85 |
F-Score7
WACC10.54%
ROIC/WACCN/A
Cap/Depr(3y)77.14%
Cap/Depr(5y)74.64%
Cap/Sales(3y)8.52%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.89%
EPS 3Y-45.83%
EPS 5Y-12.07%
EPS Q2Q%18.75%
EPS Next Y23.89%
EPS Next 2Y38.51%
EPS Next 3Y34.3%
EPS Next 5Y29.43%
Revenue 1Y (TTM)-8.15%
Revenue growth 3Y8.51%
Revenue growth 5Y-3.41%
Sales Q2Q%-16.7%
Revenue Next Year-9.78%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.64%
Revenue Next 5Y2.23%
EBIT growth 1Y55.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1010.56%
EBIT Next 3Y149.86%
EBIT Next 5Y112.74%
FCF growth 1Y182.14%
FCF growth 3Y-48.98%
FCF growth 5Y-28.07%
OCF growth 1Y759.23%
OCF growth 3Y-30.52%
OCF growth 5Y-11.17%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
Can you provide the valuation status for AZENTA INC?
ChartMill assigns a valuation rating of 3 / 10 to AZENTA INC (AZTA). This can be considered as Overvalued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
What is the financial health of AZENTA INC (AZTA) stock?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
Is the dividend of AZENTA INC sustainable?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.